Expand BOLT Menu
BOLT MENU

Bolt Biotherapeutics (BOLT) closed at $5.65 on November 17, 2026, down 2.6% from the previous close, on volume of 84,813 shares (30-day average 502,990).

Key numbers
  • Last close: $5.65 (November 17, 2026)
  • 52-week range: $3.10 to $7.78
  • Market value: $14.7 million

Data as of November 17, 2026.

BOLT Stock Summary and Trading Ideas (Bolt Biotherapeutics | NASDAQ:BOLT)

Bolt Biotherapeutics (BOLT) Frequently Asked Questions

What does Bolt Biotherapeutics do?

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The company is focused on the clinical development of BDC-4182, its claudin 18.2 ISAC. Its other pipeline programs include CEA ISAC program a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5, or CEA; PD-L1 ISAC utilizes a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker; and BDC-3042, its dectin-2 agonist antibody program, developed to repolarize critical cells in the tumor microenvironment known as tumor associated macrophages. It operates in single segment.

What symbol and exchange does Bolt Biotherapeutics shares trade?

Bolt Biotherapeutics trades on the NASDAQ stock market under the symbol BOLT.

What is Bolt Biotherapeutics stock price doing today?

As of November 17, 2026, BOLT stock price declined to $5.65 with 84,813 million shares trading.

What is Bolt Biotherapeutics's Beta?

BOLT has a beta of 0.05, meaning it tends to be less sensitive to market movements. BOLT has a correlation of 0.00 to the broad based SPY ETF.

How much is Bolt Biotherapeutics worth?

BOLT has a market cap of $14.73 million. This is considered a Sub-Micro Cap stock.

How much money does Bolt Biotherapeutics make?

Last quarter Bolt Biotherapeutics reported $0 in Revenue and -$2.25 earnings per share. This fell short of revenue expectation by $-300,000 and exceeded earnings estimates by $1.18.

What is the highest and lowest price Bolt Biotherapeutics traded in the last 3 year period?

In the last 3 years, BOLT traded as high as $31.20 and as low as $3.10.

What are the top ETFs holding Bolt Biotherapeutics?

The top ETF exchange traded funds that BOLT belongs to (by Net Assets): VXF.

Is Bolt Biotherapeutics (BOLT) a good investment?

BOLT has outperformed the market in the last year with a return of +25.3%, while the SPY ETF gained +11.2%. In the last 3 month period, BOLT beat the market returning +76.6%, while SPY returned -5.0%. However, in the most recent 2 weeks BOLT has underperformed the stock market by returning -14.0%, while SPY returned -2.9%.

What are the support and resistance levels for Bolt Biotherapeutics (BOLT)?

BOLT support price is $5.46 and resistance is $6.14 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BOLT shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes